Suchergebnisse - "Liu, Xinglong"

PubPharm (8)

1

Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews

enthalten in: Emerging microbes & infections | 2024

von Liu, X. | Li, Z. | Li, X. | +17

2

Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection

enthalten in: Journal of virology | 2022

von Zhang, Y. | Yan, Q. | Luo, K. | +18

3

Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients

enthalten in: Emerging microbes & infections | 2021

von Yan, Q. | He, P. | Huang, X. | +21

4

Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fcγ Receptor-Dependent and -Independent Pathways

enthalten in: mBio | 2021

von Yu, L. | Liu, X. | Ye, X. | +19

5

Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient

enthalten in: Frontiers in immunology | 2021

von Lai, C. | Liu, X. | Yan, Q. | +22

6

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

enthalten in: Nature communications | 2020

von Feng, L. | Wang, Q. | Shan, C. | +28

7

Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model

enthalten in: Emerging microbes & infections | 2019

von Niu, X. | Zhao, L. | Qu, L. | +24

8

Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity

enthalten in: Virology | 2018

von Feng, Y. | Sun, X. | Ye, X. | +14

1
[1]